Lifordi Immunotherapeutics
Targeting Delivery, Maximizing Therapeutic Impact
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredJun 30, 2023 (3 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
JR
Jay Rothstein Scientific Co-Founder and Advisorsource: lifordi.comAT
Arthur Tzianabos Chief Executive Officer
Investors
Companies like Lifordi Immunotherapeutics
CCity TherapeuticsSeries B+ · Aug 2026
GGranite Bio$30M Series A · Apr 2025
AAsta BioOOrbital TherapeuticsSeries A · Aug 2025
FFoRx Therapeutics$50M Series A · Dec 2025
RRgenta TherapeuticsSeries B+ · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/lifordi-immunotherapeutics (get a free API key).